Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-081337)

Filing Details

Accession Number:: 0001104659-20-081337
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-06 17:24:22
Reporting Period:: 2020-07-01

Accepted Time:: 2020-07-06 17:24:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1280600	Acceleron Pharma Inc	XLRN	Pharmaceutical Preparations (2834)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
14272	Bristol Myers Squibb Co	430 E. 29Th Street 14 Floor New York NY 10016		No	No	Yes	No
816284	Celgene Corp /De/	86 Morris Avenue Summit NJ 07901		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-07-01	108,108	$92.50	6,971,772	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This statement is being filed jointly by Celgene Corporation and Bristol-Myers Squibb Company.
These shares are owned directly by Celgene Corporation, which is a wholly owned subsidiary of Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is an indirect beneficial owner of the reported securities.